The presence of two precursors has recently been reported. Studies demonstrating the presence of dynorphin A immunoreactivity <11> in NG l08CClS cells suggested the presence of prodynorphin and the subsequent finding of O-endorphin immunoreactivity <4> indicated the existence of the proopiomelanocortin precursor.
Th e data communicated so far prompted investigations as to whether these hybrid cells are also equipped with the third know n opioid precursor, proenk ephalin A. The presence o f three opioid precursors and their cleavage products in a sing le hybrid cell line would be compatib le with the noti on that a neuron may cont ain several neuroactive agents <20> and as such wou ld provid e the opportunity to study the regu lati on of all three opioid precursors under identical condit ion s .
METHODS

Hybrid cells
(NG 108CClS) were raised as described by Hamprecht <1>. Briefly, confluent monolayers of cells were washed three times with cold phosphate buffered saline and harvested by'shaking. The cells were pelleted at 1000 x g (10 min) and stored at -70 o C. For the extraction of opioid peptides each batch (S x 10 7 cells) was treated with boiling HCI (O.lM, 0.4ml per 10 7 cells) for 10 min. After centrifugation (10 min, 10.000 x g) the supernatant was submitted to affinity chromatography (O.S x S.O cm column).
The affinity gel consisted of sepharose linked to an anti-B-endorphin monoclonal antibody (3-E7) <4>. This 3-E7 antibody recognizes the amino acid sequence Tyr-Gly-Gly-Phe-Leu/Met, the common N-terminal sequence of all endogenous opioids, and, thus, common to the five opioid peptides here under investigation. The opioid-like material was elut ed with 10 ml 2.SM acetic acid and subsequently lyophilized. The content of the different opioid peptides in the samples was determined by radioimmunoassay (RIA), using highly specif~c antisera. Each peptide assay refers to a sample of S x 10 cells. The immunoreactivity of the following peptides was measured (references for RIA protocol given in brackets): dynorphin A, dynorphin A 1-8 and a-neoendorphin <S>, O-endorphin <6>, heptapeptide <7>. Additional assays were carried out for the octapeptide <7> and peptide F-amid <18>. Respective crossreactivities of the used antisera to other opioids as measured by displacement curves were below 0.01%. An exception is dynorphin A antiserum which recognized dynorphin A 1-8 with a crossreactivity of O.OS%.
Gel chromatography:
Chromatography was carried out in acetic acid (1 M) on a G50 Sephadex (superfine) column (0.9 cm x 90 cm).
Columns were calibrated with bovine serum albumin, n-neoendorphin, ±: standard error of the mean; n-number of experiments; re= recovery in percent;
A direct comparison of peptide concentrations is permitted by the fact that they were obtained from cells raised and assayed under identical experimental conditions. The highest concentration measured was the heptapeptide-like immunoreactivity. Table I shows it to be the most abundant of the five opio i d peptids assayed: its concentration being twice the amount of a-neoendorphin. The heptapeptid-like immunoreactivity was verified by HPLC analysis of the affinity column purified eluates. The affinity column eluates were also examined for other peptides which are derived solely from proenkephalin A. A high specific antiserum (detection limit: 10 fmol/tube) failed to reveal significant amounts of the octapeptide (Tyr-Gly-Gly-Phe-Met-Arg-Gly-Leu).
In addition, attempts were made to detect the proenkephalin A derived peptide F amid to see whether NG l08CCl5 cells are able to amidate opioids. A search ~n five batches showed no detectable amount (detection limit 100 fmol/tube). However the possibility of amidation of other opioid peptides can not be ruled out.
DISCUSSION
This study investigates th e issue wh ethe r NG l08CCl5 hybrid cells express the three known opioid peptide precursors.
We report here the presence of immunore a ctive opioid peptides known to originate from preproenkeph a lin A, prodynorphin and proopiomelanocortin.
This finding strongly suggests the expres s i on of this precursor s . Moreover, this permits a comparison o f peptides fr om three different opioid precursors in one homogenous cell type grown under identical conditions, in contrast to the situation i n tissu es <19> or even in primary cultures.
Thus the NG l08CC15 cells represent an interesting example for the coexistence <20> of a neuronal transmitter (acetylcholin <21» with opioid peptides. Studies on Ehe modulation of enkephalin content in hybrid cells have already been successfully conducted <15,17>. However, previously reported leu-and met-enkephalin in NG 108CC15 cells <12,13> could originate both from prodynorphin, from proenkephalin A or from proopiomelanocortin. In contrast heptapeptide as well as the octapeptide and peptide F-amid have as their only source proenkephalin A. The documentation of heptapeptide immunoreactivity thus strongly indicates the expression of the preproenkephalin A precursor. Each peptide reported in our study is identified both at its Nand C terminus. That is, the 3-E7 monoclonal antibody recognizes the N-terminal enkephalin sequence Tyr-Gly-Gly--Phe-Met/Leu common to all opioid peptides.
The specific antisera employed here recognize the respective C-termini of the peptides. It is interesting to note that differences in precursor processing and turnover apparently lead to a concentration of a product of the preproenkephalin A gene at least 40 times higher than that of B-endorphin, the product of the proopiomelanocortiri gene. Similar differences have been reported in specific tissues <16>. The concentration of a-neoendorphin in NG 108CC15 cells is only slightly elevated in comparison to dynorphin A.
It is concluded that their processing from prodynorphin is closely related, as has been suggested for rat and human tissue <5>. In support of further processing of dynorphin A in NG l08CC15 cells we report here the occurence of dynorphin A 1-8. This peptide occurs only as a third of the concentration of dynorphin A. An analogous ratio of processing can be found in posterior pituitary (0.5:1 <10»
. In brain (rat), however, dynorphin A 1-8 dominates dynorphin A <9>. In particular, vasoactive intestinal peptide (VIP) immunoreactivity is present in concentrations ranging from 0.94 to 4.14 pmol/g protein and co-release studies for opioids, acetylcholin and VIP were suggested for this hybrid cells <22>.
The complete renin-angiotensin system has been identified in NG 108CC15 cells, angiotensin 11 content being 60 pmol/ 9 protein, renin 34 pg/mg protein and modulated in this cells <23>. 
